A Phase III, Multicenter, Open-Label, Long-Term Study of the Tolerability of Intravenous Natalizumab in Crohn's Disease Subjects Who Have Previously Participated in Natalizumab Crohn's Disease Study CD351 - CD354 A Phase III, Multicenter, Open-Label, Long-Term Study of the Tolerability of Intravenous Natalizumab ...
A Phase III, Multicenter, Open-Label, Long-Term Study of the Tolerability of Intravenous Natalizumab in Crohn's Disease Subjects Who Have Previously Participated in Natalizumab Crohn's Disease Study CD351 - CD354 A Phase III, Multicenter, Open-Label, Long-Term Study of the Tolerability of Intravenous Natalizumab ...